Search research articles
Contact Us
Filters
Showing results (131-140 of 139) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 139 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
A Four-Gene Promoter Methylation Marker Panel Consisting of <i>GREM1, NEURL, LAD1,</i> and <i>NEFH</i> Predicts Survival of Clear Cell Renal Cell Cancer Patients
Iris J H van Vlodrop, Sophie C Joosten, Tim De Meyer, et al.
The Journal of Investigative Dermatology
|
August 1, 2025
Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical Outcome
Karin van den Hurk, Kim Lommen, Louis Coussement, et al.
Molecular Oncology
|
February 25, 2014
Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients
Muriel X G Draht, Kim M Smits, Benjamin Tournier, et al.
Molecular Oncology
|
January 28, 2021
Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies
Leonie K de Klerk, Ruben S A Goedegebuure, Nicole C T van Grieken, et al.
Cancer Research
|
May 14, 2009
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer
Sabine C Glöckner, Mashaal Dhir, Joo Mi Yi, et al.
Oncotarget
|
October 4, 2017
<i>Decoy receptor 1</i> (<i>DCR1)</i> promoter hypermethylation and response to irinotecan in metastatic colorectal cancer
Linda J W Bosch, Geert Trooskens, Petur Snaebjornsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer
Debby M E I Hellebrekers, Marjolein H F M Lentjes, Sandra M van den Bosch, et al.
Journal of the National Cancer Institute
|
June 19, 2009
N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer
Veerle Melotte, Marjolein H F M Lentjes, Sandra M van den Bosch, et al.
Gastroenterology
|
September 1, 2024
Stool-Based Testing for Post-Polypectomy Colorectal Cancer Surveillance Safely Reduces Colonoscopies: The MOCCAS Study
Beatriz Carvalho, Willemijn de Klaver, Francine van Wifferen, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 139) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 139 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
A Four-Gene Promoter Methylation Marker Panel Consisting of <i>GREM1, NEURL, LAD1,</i> and <i>NEFH</i> Predicts Survival of Clear Cell Renal Cell Cancer Patients
Iris J H van Vlodrop, Sophie C Joosten, Tim De Meyer, et al.
The Journal of Investigative Dermatology
|
August 1, 2025
Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical Outcome
Karin van den Hurk, Kim Lommen, Louis Coussement, et al.
Molecular Oncology
|
February 25, 2014
Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients
Muriel X G Draht, Kim M Smits, Benjamin Tournier, et al.
Molecular Oncology
|
January 28, 2021
Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies
Leonie K de Klerk, Ruben S A Goedegebuure, Nicole C T van Grieken, et al.
Cancer Research
|
May 14, 2009
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer
Sabine C Glöckner, Mashaal Dhir, Joo Mi Yi, et al.
Oncotarget
|
October 4, 2017
<i>Decoy receptor 1</i> (<i>DCR1)</i> promoter hypermethylation and response to irinotecan in metastatic colorectal cancer
Linda J W Bosch, Geert Trooskens, Petur Snaebjornsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer
Debby M E I Hellebrekers, Marjolein H F M Lentjes, Sandra M van den Bosch, et al.
Journal of the National Cancer Institute
|
June 19, 2009
N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer
Veerle Melotte, Marjolein H F M Lentjes, Sandra M van den Bosch, et al.
Gastroenterology
|
September 1, 2024
Stool-Based Testing for Post-Polypectomy Colorectal Cancer Surveillance Safely Reduces Colonoscopies: The MOCCAS Study
Beatriz Carvalho, Willemijn de Klaver, Francine van Wifferen, et al.
Page
of 14